| The chemistry and biology of soluble guanylate cyclase stimulators and activators M Follmann, N Griebenow, MG Hahn, I Hartung, FJ Mais, J Mittendorf, ... Angewandte Chemie International Edition 52 (36), 9442-9462, 2013 | 233 | 2013 |
| 8‐Oxabicyclo [3.2. 1] oct‐6‐en‐3‐ones: Application to the Asymmetric Synthesis of Polyoxygenated Building Blocks IV Hartung, HMR Hoffmann Angewandte Chemie International Edition 43 (15), 1934-1949, 2004 | 144 | 2004 |
| Electronic and steric control of regioselectivities in Rh (I)-catalyzed (5+ 2) cycloadditions: experiment and theory P Liu, LE Sirois, PHY Cheong, ZX Yu, IV Hartung, H Rieck, PA Wender, ... Journal of the American Chemical Society 132 (29), 10127-10135, 2010 | 128 | 2010 |
| Donated chemical probes for open science S Müller, S Ackloo, CH Arrowsmith, M Bauser, JL Baryza, J Blagg, ... elife 7, e34311, 2018 | 94 | 2018 |
| Isoform-selective ATAD2 chemical probe with novel chemical structure and unusual mode of action AE Fernández-Montalván, M Berger, B Kuropka, SJ Koo, V Badock, ... ACS chemical biology 12 (11), 2730-2736, 2017 | 79 | 2017 |
| Discovery and characterization of a highly potent and selective aminopyrazoline-based in vivo probe (BAY-598) for the protein lysine methyltransferase SMYD2 E Eggert, RC Hillig, S Koehr, D Stöckigt, J Weiske, N Barak, J Mowat, ... Journal of medicinal chemistry 59 (10), 4578-4600, 2016 | 75 | 2016 |
| Discovery of molidustat (BAY 85‐3934): a small‐molecule oral HIF‐prolyl hydroxylase (HIF‐PH) inhibitor for the treatment of renal anemia H Beck, M Jeske, K Thede, F Stoll, I Flamme, M Akbaba, JK Ergüden, ... ChemMedChem 13 (10), 988-1003, 2018 | 63 | 2018 |
| Benzoisoquinolinediones as potent and selective inhibitors of BRPF2 and TAF1/TAF1L bromodomains L Bouché, CD Christ, S Siegel, AE Fernández-Montalván, SJ Holton, ... Journal of Medicinal Chemistry 60 (9), 4002-4022, 2017 | 55 | 2017 |
| Target 2035–update on the quest for a probe for every protein S Müller, S Ackloo, A Al Chawaf, B Al-Lazikani, A Antolin, JB Baell, ... RSC Medicinal Chemistry 13 (1), 13-21, 2022 | 49 | 2022 |
| Toward the Total Synthesis of Disorazole A1 and C1: Asymmetric Synthesis of a Masked Southern Segment IV Hartung, B Niess, LO Haustedt, HMR Hoffmann Organic Letters 4 (19), 3239-3242, 2002 | 46 | 2002 |
| 8‐Oxabicyclo [3.2. 1] oct‐6‐en‐3‐one: Anwendungen in der asymmetrischen Synthese polyoxygenierter Bausteine IV Hartung, HMR Hoffmann Angewandte Chemie 116 (15), 1968-1984, 2004 | 41 | 2004 |
| The total syntheses of phorboxazoles—new classics in natural product synthesis LO Haustedt, IV Hartung, HMR Hoffmann Angewandte Chemie International Edition 42 (24), 2711-2716, 2003 | 40 | 2003 |
| Rules were made to be broken IV Hartung, BR Huck, A Crespo Nature Reviews Chemistry 7 (1), 3-4, 2023 | 33 | 2023 |
| Expanding chemical probe space: quality criteria for covalent and degrader probes IV Hartung, J Rudolph, MM Mader, MPC Mulder, P Workman Journal of Medicinal Chemistry 66 (14), 9297-9312, 2023 | 31 | 2023 |
| Synthetic studies toward the disorazoles: synthesis of a masked northern half of disorazole D1 and a cyclopropane analog of the masked northern half of disorazole A1 LO Haustedt, SB Panicker, M Kleinert, IV Hartung, U Eggert, B Niess, ... Tetrahedron 59 (35), 6967-6977, 2003 | 31 | 2003 |
| Identifying palladium culprits in amine catalysis M Avanthay, RB Bedford, CS Begg, D Boese, J Clayden, SA Davis, ... Nature Catalysis 4 (12), 994-998, 2021 | 27 | 2021 |
| Quantification of histone H3 Lys27 trimethylation (H3K27me3) by high-throughput microscopy enables cellular large-scale screening for small-molecule EZH2 inhibitors S Luense, P Denner, A Fernández-Montalván, I Hartung, M Husemann, ... Journal of biomolecular screening 20 (2), 190-201, 2015 | 23 | 2015 |
| Systematic potency and property assessment of VHL ligands and implications on PROTAC design J Krieger, FJ Sorrell, AA Wegener, B Leuthner, F Machrouhi‐Porcher, ... ChemMedChem 18 (8), e202200615, 2023 | 22 | 2023 |
| Stereochemical assignment of intermediates in the rifamycin biosynthetic pathway by precursor-directed biosynthesis IV Hartung, MA Rude, NA Schnarr, D Hunziker, C Khosla Journal of the American Chemical Society 127 (32), 11202-11203, 2005 | 21 | 2005 |
| Optimization of allosteric MEK inhibitors. Part 1: Venturing into underexplored SAR territories IV Hartung, M Hitchcock, F Pühler, R Neuhaus, A Scholz, S Hammer, ... Bioorganic & medicinal chemistry letters 23 (8), 2384-2390, 2013 | 18 | 2013 |
